FRIDAY, April 3, 2026 -- While uncommon, use of complementary and alternative medicine (CAM) instead of traditional therapies is associated with lower survival time in females with breast cancer , according to a study published online March 2 in JAMA Network Open . Oluwaseun F. Ayoade, M.D., from Yale University in New Haven, Connecticut, and colleagues examined the association of CAM with survival in females with breast cancer. Analysis included ~2.16 million female patients with breast cancer

SAN DIEGO, April 03, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on April 1, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of nonstatutory stock options to purchase 153,750 shares of common stock to six (6) new employees under the Company

A new clinical trial suggests that what people eat could finally offer real relief for Crohn’s disease, a condition that has long lacked clear dietary guidance. Researchers found that a “fasting-mimicking diet” — involving just five days a month of very low-calorie, plant-based meals — led to noticeable improvements in symptoms for most participants. Even more striking, the diet didn’t just make patients feel better; it also reduced key biological markers of inflammation linked to the disease."W

MARSEILLE, France--(BUSINESS WIRE)-- #Biotech --Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate in one-on-one investor meetings at the following conference: Kempen Life Sciences Conference Dates: April 15 –16, 2026 Location: Amsterdam, Netherlands About Innate Pharma Innate Pharma S.A. is

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on April 1, 2026, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering 31,625 shares of Puma common stock to five new non-executive employees. The awards were granted under Puma’s 2017 Employment Inducement Incentive Award Plan, which was adopted on April 27, 2017 and provides for the granting of equity awards

FRIDAY, April 3, 2026 -- Older patients with coronary artery disease scheduled for transcatheter aortic valve replacement (TAVR) have comparable outcomes regardless of whether they undergo percutaneous coronary intervention (PCI) before TAVR, according to a study presented at the annual meeting of the American College of Cardiology, held from March 28 to 30 in New Orleans. Ronak Delewi, M.D. Ph.D., from University Medical Center Utrecht in the Netherlands, and colleagues examined the need for r

On March 27, 2026, Hansoh Pharmaceutical Group Co., Ltd. (hereinafter referred to as “Hansoh Pharma,” stock code: 03692.HK) announced that its innovative drug XINYUE (Inebilizumab Injection) has been approved by the National Medical Products Administration (NMPA) for marketing, which marks the drug’s third approved indication: in combination with conventional therapies, this product is indicated for the treatment of adult patients with anti-acetylcholine receptor (AChR) or anti-muscle-specific k

The University of Colorado Anschutz Gates Institute announced FDA clearance for an Investigational New Drug (IND) application for a CD64-directed CAR T-cell therapy in adults with relapsed or refractory acute myeloid leukemia, as per an announcement. The clearance marks the first CAR T-cell therapy developed entirely on a US academic campus to receive FDA authorization for clinical testing, according to the Gates Institute. Enrollment in the Phase I first-in-human study is anticipated to begin i

CLEVELAND - As you're drinking your morning coffee, you may be glad to hear that a cup of joe may help reduce your risk for dementia. That’s according to a recent study involving more than 130,000 people. “This study was in line with previous studies that have shown a reduction in dementia risk and cognitive decline risk in individuals who ingest coffee and tea. This particular study was also careful to include individuals who ingested decaffeinated coffee. So, they were able to look at the diff

NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (the “Company”) (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative γδ T cell therapies for cancer and autoimmune diseases, today announced that the Compensation Committee of the Company’s Board of Directors granted two employees nonqualified stock options to purchase an aggregate of 11,800 shares of its common stock. The awards were approved by the Compensation Committee of the Company’s Board of Directors an